[EN] COMBINATION PRODUCT FOR THE TREATMENT OF CANCER DISEASES<br/>[FR] PRODUIT DE COMBINAISON POUR LE TRAITEMENT DE MALADIES CANCÉREUSES
申请人:MERCK PATENT GMBH
公开号:WO2021249969A1
公开(公告)日:2021-12-16
The present invention relates to a product for combination therapies useful for the treatment of cancer diseases. In particular, the invention relates to the combination of an anti-PD-Ll antibody and an MCT4 inhibitor of Formula (I). The therapeutic combination may be utilized for the use in treating a subject having a cancer disease that tests positive for PD-L1 and/or MCT4 expression.
The present invention relates to disubstituted alkyne derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.